ResearcherPeking University Third HospitalActive in the last 2 years
Wenzhe Si
Matched on ORCID iD 0000-0003-1573-9337; OpenAlex author ID A5037083055. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 7
2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 3 papers
Papers 5
- The histone acylation network: emerging therapeutic targets for remodeling the epigenetic landscape in pancreatic ductal adenocarcinoma. Last author DOI 10.1007/s13402-026-01191-9↗
- Molecular Subtype Identification and Prognostic Prediction of Pancreatic Cancer Based on m6A/m5C/m1A-Related Genes. Last author DOI 10.1111/jcmm.71251↗
- Histone lactylation boosted SET8 potentiates carcinogenesis and angiogenesis of pancreatic ductal adenocarcinoma by cooperating with MTA1/NuRD complex. Last author DOI 10.1186/s12967-026-08424-3↗
- Positive feedback regulation between glycolysis and histone lactylation drives oncogenesis in pancreatic ductal adenocarcinoma. First author DOI 10.1186/s12943-024-02008-9↗
- MTA2-mediated inhibition of PTEN leads to pancreatic ductal adenocarcinoma carcinogenicity. Co-author DOI 10.1038/s41419-019-1424-5↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xujun Liu · 4 shared papers, 2019–2026 · strength 1.02
- Paper The histone acylation network: emerging therapeutic targets for remodeling the epigenetic landscape in pancreatic ducta… DOI 10.1007/s13402-026-01191-9↗
- Paper Histone lactylation boosted SET8 potentiates carcinogenesis and angiogenesis of pancreatic ductal adenocarcinoma by coo… DOI 10.1186/s12967-026-08424-3↗
- Paper Molecular Subtype Identification and Prognostic Prediction of Pancreatic Cancer Based on m6A/m5C/m1A-Related Genes. DOI 10.1111/jcmm.71251↗
- Tianpei Hong · 2 shared papers, 2019–2024 · strength 0.32
- Rui Wei · 2 shared papers, 2019–2024 · strength 0.32
- Deju Anna Kong · 1 shared paper, 2026 · strength 0.32
- Xiaodong Tian · 1 shared paper, 2026 · strength 0.32
- Yunyang Wang · 1 shared paper, 2026 · strength 0.28
- Fei Li · 1 shared paper, 2024 · strength 0.21
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.